Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sartorius, Sanofi Partner to Develop End-to-End Platform for Downstream Process Intensification | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Sartorius, Sanofi Partner to Develop End-to-End Platform for Downstream Process Intensification

Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing platform.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing (ICB).
 
Integrated continuous biomanufacturing is an advanced approach to the production of biopharmaceuticals, which aims to maximize efficiency by enabling uninterrupted and steady materials flow, as opposed to traditional batch methods, and by integrating multiple unit operations into a lean process setup. ICB reduces the overall process footprint, leading to lower raw material and energy consumption, higher productivity, and less waste.
 
Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to commercialize ICB platforms based on prototypes developed by Sanofi. In return, Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform.
 
As part of the collaboration and license agreement, Sartorius will exclusively commercialize the ICB platform offering to customers worldwide.
 
“As the biologics landscape becomes more diverse, teaming up with Sanofi is an excellent basis for developing a unique modular platform that combines flexibility with the advantages of intensified bioprocessing. This collaboration will help Sartorius to further expand its position as a leading company in the field of integrated and continuous bioprocessing,” said Jan Schäfer, Head of Separation Systems at Sartorius.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics